Apoptosis protection by the Epo target Bcl-XL allows factor-independent differentiation of primary erythroblasts

被引:116
作者
Dolznig, H
Habermann, B
Stangl, K
Deiner, EM
Moriggl, R
Beug, H
Müllner, EW
机构
[1] Vienna Bioctr, Inst Mol Pathol, A-1030 Vienna, Austria
[2] Inst Med Biochem, Div Mol Biol, A-1030 Vienna, Austria
关键词
D O I
10.1016/S0960-9822(02)00930-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Erythropoietin (Epo) is required for correct execution of the erythroid differentiation program. Erythropoiesis requires Bcl-X-L, a major late target of Epo-receptor signaling. Mice lacking Bcl-X-L die around embryonic age E12.5, forming normal erythroid progenitors but lacking functional red cells. Recently, serum-free culture conditions for expansion of murine red cell progenitors were developed, yielding cells capable of in vivo-like terminal differentiation into enucleated erythrocytes, in response to Epo/insulin. Here we address whether Epo function during terminal maturation involves a cytokine-independent "default program," requiring only apoptosis inhibition through Epo-dependent upregulation of Bcl-X-L. Results: Exogenous expression of Bcl-X-L or Bcl-2 in primary murine erythroblasts or clonal erythroblast lines derived from p53(-/-) mice allowed these cells to undergo terminal erythroid maturation, in the complete absence of cytokines. A potential autocrine Epo loop was ruled out by respective neutralizing antibodies. Importantly, sustained proliferation Of Bcl-X-L-expressing immature erythroblasts still required respective factors (Epo, stem cell factor [SCF], and the glucocorticoid receptor ligand dexamethasone [Dex]). Epo-independent differentiation in these Bcl-X-L- or Bcl-2-expressing, primary erythroblasts was thus triggered by removal of the renewal factors SCF and Dex. This initiated the maturation-specific expression cascade of erythroid transcription factors, followed by differentiation divisions (characterized by a short G1 phase and decrease in cell size), hemoglobin accumulation, and enucleation. Conclusions: During erythroid maturation, Epo regulates red cell numbers via apoptosis inhibition, caused by Epo-dependent upregulation of the antiapoptotic protein Bcl-XL. This allows "default" terminal differentiation of apoptosis-protected, committed erythroblasts, independent of any exogenous signals.
引用
收藏
页码:1076 / 1085
页数:10
相关论文
共 45 条
[41]   The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors [J].
Wessely, O ;
Deiner, EM ;
Beug, H ;
vonLindern, M .
EMBO JOURNAL, 1997, 16 (02) :267-280
[42]   GENERATION OF COMMITTED ERYTHROID BFU-E AND CFU-E PROGENITORS DOES NOT REQUIRE ERYTHROPOIETIN OR THE ERYTHROPOIETIN RECEPTOR [J].
WU, H ;
LIU, X ;
JAENISCH, R ;
LODISH, HF .
CELL, 1995, 83 (01) :59-67
[43]   The CIS/JAB family: novel negative regulators of JAK signaling pathways [J].
Yoshimura, A .
LEUKEMIA, 1998, 12 (12) :1851-1857
[44]   A NOVEL CYTOKINE-INDUCIBLE GENE CIS ENCODES AN SH2-CONTAINING PROTEIN THAT BINDS TO TYROSINE-PHOSPHORYLATED INTERLEUKIN-3 AND ERYTHROPOIETIN RECEPTORS [J].
YOSHIMURA, A ;
OHKUBO, T ;
KIGUCHI, T ;
JENKINS, NA ;
GILBERT, DJ ;
COPELAND, NG ;
HARA, T ;
MIYAJIMA, A .
EMBO JOURNAL, 1995, 14 (12) :2816-2826
[45]  
YU H, 1993, BLOOD, V81, P373